Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Scotiabank Maintains Sector Outperform on Twist Bioscience, Raises Price Target to $43

Author: Benzinga Newsdesk | February 05, 2024 02:18pm
Scotiabank analyst Sung Ji Nam maintains Twist Bioscience (NASDAQ:TWST) with a Sector Outperform and raises the price target from $30 to $43.

Posted In: TWST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist